文献速递神经肿瘤

近红外荧光图像引导手术治疗颅内脑膜瘤

Near-infrared fluorescent image-guided surgery for intracranial meningioma.
PubMed 文献 · J Neurosurg · 2017-04-07

18例颅内脑膜瘤患者术前接受5 mg/kg近红外荧光染料ICG「第二窗口」注射,术中近红外成像定位肿瘤和切缘,14例肿瘤信号背景比显著升高(5.6±1.7),4例出现反转模式(信号背景比0.31±0.1),该技术对肿瘤检测的灵敏度为96.4%、特异度为38.9%。

要点

  • 术前一天静脉注射5 mg/kg ICG「第二窗口」,术中近红外成像可术中可视化脑膜瘤。
  • 18例中14例肿瘤信号背景比显著升高(5.6±1.7),4例出现正常脑组织信号强于肿瘤的反转模式(0.31±0.1)。
  • 近红外成像识别脑膜瘤的灵敏度高于肉眼,灵敏度96.4%、特异度38.9%。

核心结论

  • 术前一天全身注射近红外「第二窗口」ICG可在术中可视化脑膜瘤。
  • 术中近红外成像识别脑膜瘤的灵敏度高于肉眼。
  • 18例中14例肿瘤较相邻脑组织显示强信号背景比。
  • 缩短染料注射与术中成像的时间间隔可能改善切缘荧光,但该方法需进一步研究。

研究设计与样本

  • 前瞻性识别18例患者,术前一天接受5 mg/kg「第二窗口」ICG,术中使用近红外相机定位肿瘤并检查切缘。
  • 对肿瘤与正常脑实质的信号背景比进行三次重复测量,对肿瘤大体和切缘标本进行荧光定性报告。
  • 以神经病理学诊断为参考金标准计算该成像技术的灵敏度和特异度。

主要发现

  • 18例患者中15例为WHO I级、3例为WHO II级脑膜瘤。
  • 术中近红外可视化时间为「第二窗口」ICG输注后18至28小时(平均23小时)。
  • 18例肿瘤中14例信号背景比为5.6±1.7,较相邻脑实质明显升高。
  • 18例中4例出现近红外信号反转模式,即相邻正常脑组织信号强于肿瘤(信号背景比0.31±0.1)。
  • 该技术对肿瘤的灵敏度为96.4%、特异度为38.9%、阳性预测值为71.1%、阴性预测值为87.5%。

关键数值与推荐

  • 肿瘤与正常脑实质信号背景比在14例中为5.6±1.7,在4例反转模式中为0.31±0.1。
  • 近红外成像对肿瘤的灵敏度96.4%、特异度38.9%、阳性预测值71.1%、阴性预测值87.5%。
  • 信号反转的最佳预测因素是注射后时间,成像较早的患者更可能出现适当的信号背景比。

临床怎么用

  • 术前一天全身注射近红外「第二窗口」ICG可用于术中可视化脑膜瘤。
  • 作者认为缩短染料注射至术中成像的时间间隔可能改善切缘荧光,但该方法需进一步研究。

局限性

  • 18例中4例出现信号反转模式,成像较早的患者更可能出现适当信号背景比。
  • 缩短染料注射至术中成像的时间间隔以改善切缘荧光的方法需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Meningiomas are the most common primary tumor of the central nervous system. Complete resection can be curative, but intraoperative identification of dural tails and tumor remnants poses a clinical challenge. Given data from preclinical studies and previous clinical trials, the authors propose a novel method of localizing tumor tissue and identifying residual disease at the margins via preoperative systemic injection of a near-infrared (NIR) fluorescent contrast dye. This technique, what the authors call "second-window indocyanine green" (ICG), relies on the visualization of ICG approximately 24 hours after intravenous injection. METHODS Eighteen patients were prospectively identified and received 5 mg/kg of second-window ICG the day prior to surgery. An NIR camera was used to localize the tumor prior to resection and to inspect the margins following standard resection. The signal to background ratio (SBR) of the tumor to the normal brain parenchyma was measured in triplicate. Gross tumor and margin specimens were qualitatively reported with respect to fluorescence. Neuropathological diagnosis served as the reference gold standard to calculate the sensitivity and specificity of the imaging technique. RESULTS Eighteen patients harbored 15 WHO Grade I and 3 WHO Grade II meningiomas. Near-infrared visualization during surgery ranged from 18 to 28 hours (mean 23 hours) following second-window ICG infusion. Fourteen of the 18 tumors demonstrated a markedly elevated SBR of 5.6 ± 1.7 as compared with adjacent brain parenchyma. Four of the 18 patients showed an inverse pattern of NIR signal, that is, stronger in the adjacent normal brain than in the tumor (SBR 0.31 ± 0.1). The best predictor of inversion was time from injection, as the patients who were imaged earlier were more likely to demonstrate an appropriate SBR. The second-window ICG technique demonstrated a sensitivity of 96.4%, specificity of 38.9%, positive predictive value of 71.1%, and a negative predictive value of 87.5% for tumor. CONCLUSIONS Systemic injection of NIR second-window ICG the day before surgery can be used to visualize meningiomas intraoperatively. Intraoperative NIR imaging provides higher sensitivity in identifying meningiomas than the unassisted eye. In this study, 14 of the 18 patients with meningioma demonstrated a strong SBR compared with adjacent brain. In the future, reducing the time interval from dye injection to intraoperative imaging may improve fluorescence at the margins, though this approach requires further investigation. Clinical trial registration no.: NCT02280954 ( clincialtrials.gov ).

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lee JYK, Pierce JT, Thawani JP, et al. Near-infrared fluorescent image-guided surgery for intracranial meningioma. J Neurosurg. 2017. PMID: 28387632. doi:10.3171/2016.10.JNS161636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。